Clinical outsourcing limits innovation in bio Pharma – Research Study 2011

December 22, 2011: A recent research has found that offshoring of clinical research might hamper innovation and open up opportunities for smaller competitors. Large pharmaceutical companies have intensified outsourcing to research organizations in an effort to cut fixed cost and enhance flexibility as the patents are due to expire shortly. This move to outsource drug […]